These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24576472)

  • 61. Prevalence of antibodies to polioviruses & enteroviruses excreted by healthy children in Bombay.
    Deshpande JM; Kamat JR; Rao VK; Nadkarni SS; Kher AS; Salgaokar SD; Rodrigues JJ
    Indian J Med Res; 1995 Feb; 101():50-4. PubMed ID: 7729847
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
    Asturias EJ; Bandyopadhyay AS; Self S; Rivera L; Saez-Llorens X; Lopez E; Melgar M; Gaensbauer JT; Weldon WC; Oberste MS; Borate BR; Gast C; Clemens R; Orenstein W; O'Ryan G M; Jimeno J; Clemens SA; Ward J; Rüttimann R;
    Lancet; 2016 Jul; 388(10040):158-69. PubMed ID: 27212429
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Immunity to poliovirus after vaccination of children with type 1 diabetes mellitus and rheumatic diseases].
    Tarasova AA; Kniagina ON; Kalashnikova NA; Kostinov MP; Erukhimov VL
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (5):52-6. PubMed ID: 20063794
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.
    Wright PF; Connor RI; Wieland-Alter WF; Hoen AG; Boesch AW; Ackerman ME; Oberste MS; Gast C; Brickley EB; Asturias EJ; Rüttimann R; Bandyopadhyay AS
    Lancet Infect Dis; 2016 Dec; 16(12):1377-1384. PubMed ID: 27638357
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan.
    Reichler MR; Kharabsheh S; Rhodes P; Otoum H; Bloch S; Majid MA; Pallansch MA; Patriarca PA; Cochi SL
    J Infect Dis; 1997 Feb; 175 Suppl 1():S198-204. PubMed ID: 9203717
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.
    Qiu J; Yang Y; Huang L; Wang L; Jiang Z; Gong J; Wang W; Wang H; Guo S; Li C; Wei S; Mo Z; Xia J
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28362135
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polio immunity and the impact of mass immunization campaigns in the Democratic Republic of the Congo.
    Voorman A; Hoff NA; Doshi RH; Alfonso V; Mukadi P; Muyembe-Tamfum JJ; Wemakoy EO; Bwaka A; Weldon W; Gerber S; Rimoin AW
    Vaccine; 2017 Oct; 35(42):5693-5699. PubMed ID: 28882442
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Deficiency of immunity to poliovirus type 3: a lurking danger?
    Reinheimer C; Friedrichs I; Rabenau HF; Doerr HW
    BMC Infect Dis; 2012 Jan; 12():24. PubMed ID: 22280025
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunity status to poliovirus in Veneto region (north-east Italy). A seroepidemiological survey.
    Trivello R; Farisano G; Bonello C; Moschen ME; Baldo V; Majori S; Moretti G; Marin V; Piron L; Renzulli G
    Ann Clin Lab Sci; 1994; 24(6):542-7. PubMed ID: 7847782
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman.
    Sutter RW; Suleiman AJ; Malankar PG; Mehta FR; Medany MA; Arif MA; Linkins RW; Pallansch MA; El-Bualy MS; Robertson SE
    J Infect Dis; 1997 Feb; 175 Suppl 1():S235-40. PubMed ID: 9203722
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High level of immunity against poliomyelitis in Albanian refugees in southern Italy.
    Lopalco PL; Germinario C; Calvario A; Chironna M; Quarto M; Barbuti S
    J Travel Med; 2000; 7(3):111-5. PubMed ID: 11179938
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands.
    Oostvogel PM; Rumke HC; Conyn-Van Spaendonck MA; van der Avoort HG; Leeuwenburg J; van Loon AM
    J Infect Dis; 2001 Dec; 184(11):1451-5. PubMed ID: 11709788
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Estimating population immunity to poliovirus in Lebanon: Results from a seroprevalence survey, 2016.
    Mansour Z; Said R; Wannemuehler K; Weldon W; Estephan J; Khachan J; Warrak R; Hendley W; Ehrhardt D; Farag NH
    Vaccine; 2020 Jun; 38(31):4846-4852. PubMed ID: 32499065
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vaccination against polio. Inactivated polio vaccine used in The Netherlands and Burkina Faso.
    Rümke HC
    Trop Geogr Med; 1993; 45(5):202-5. PubMed ID: 8279056
    [No Abstract]   [Full Text] [Related]  

  • 76. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [A seroepidemiological study on the level of immunological coverage in a nomadic population in Rome].
    Porta D; Chierchini P; Bruno L; Fiore L; Cristofaro G; Amato C; Catone S; Gentili G; Sangalli M; Forastiere F
    Epidemiol Prev; 1997; 21(1):48-53. PubMed ID: 9157025
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016.
    Hussain I; Mach O; Habib A; Bhatti Z; Suhag Z; Oberste MS; Weldon WC; Sutter RW; Soofi SB; Bhutta ZA
    Pediatr Infect Dis J; 2017 Sep; 36(9):e230-e236. PubMed ID: 28806355
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Evaluation of the response to vaccination against poliomyelitis and measles in malnourished children in Morocco].
    Caidi H; Bennis IF; Mouan N; El Aouad R
    East Mediterr Health J; 2004; 10(4-5):474-81. PubMed ID: 16335637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.